SGA
AGIO icon

Sector Gamma AS’s Agios Pharmaceuticals AGIO Stock Holding History

Sector Gamma AS’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67,908
Closed -$3.02M – 31
2024
Q3 		$3.02M Sell
67,908
-53,936
-44% -$2.45M 0.92% 27
2024
Q2 		$5.25M Sell
121,844
-42,534
-26% -$1.54M 1.96% 20
2024
Q1 		$4.81M Buy
+164,378
New +$4.4M 1.35% 23
2020
Q1 		– Sell
-63,913
Closed -$3.05M – 32
2019
Q4 		$3.05M Sell
63,913
-39,000
-38% -$1.47M 0.49% 34
2019
Q3 		$3.33M Hold
102,913
– – 0.56% 32
2019
Q2 		$5.13M Buy
102,913
+45,870
+80% +$2.45M 0.83% 32
2019
Q1 		$3.85M Buy
+57,043
New +$3.32M 0.62% 30
2018
Q2 		– Sell
-41,000
Closed -$3.35M – 33
2018
Q1 		$3.35M Buy
+41,000
New +$3.17M 0.6% 28

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Sector Gamma AS's AGIO Position: Q4 2024 in Review

Sector Gamma AS sold out of Agios Pharmaceuticals (AGIO) in Q4 2024, closing a stake of 67,908 shares — an estimated $3.02M sold.

Sector Gamma AS first reported a position in AGIO in Q1 2018 and held it in 8 quarters. The position peaked at $5.25M in Q2 2024. 224 funds tracked by Wall St. Rank hold AGIO as of Q4 2024.

  • Sector Gamma AS reported no remaining Agios Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Sector Gamma AS sold 67,908 Agios Pharmaceuticals shares in Q4 2024, an estimated $3.02M.
  • Sector Gamma AS first reported a position in Agios Pharmaceuticals in Q1 2018 and held it in 8 quarters.
  • Sector Gamma AS's Agios Pharmaceuticals position peaked at $5.25M in Q2 2024.
  • 224 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2024.

Based on Sector Gamma AS's 13F filing for Q4 2024, filed 11 Feb 2025.